Cancer
EAQ202: Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Description
The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.
Inclusion Notes
For a full description of this trial, please go to the listing on www.clinicaltrials.gov
Eligibility Criteria
Inclusion Criteria:
Patient must be ≥ 18 years and ≤ 39 years of age at registration. Patient must have a histologically confirmed diagnosis of primary cancer of any stage within 12 weeks (84 days) at registration.
Patient must have received, be currently receiving or planning to receive treatment for cancer, including surgery and/or chemotherapy and/or radiation therapy.
Patient must have an ECOG performance status 0-3. Patient must have a life expectancy >24 months.
Patient must be able to complete questionnaires in English. Patient must have internet access through computer, tablet, or smartphone. Patient must have an email address. Patient must have a mobile phone able with text messaging capabilities. Patient must be able to accurately provide self-report data (e.g. per clinical judgment, cognitive function is intact).
Patient must be able to provide informed consent.
Exclusion Criteria:
Patient must not have a recurrence or second primary cancer. Patients must not have basal cell skin carcinoma.
Start Date
Wednesday, August 17, 2022
Principal / Contact Name
Mark A. Taylor, MD